NASDAQ:ACB • CA05156X8504
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AURORA CANNABIS INC (ACB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-06-27 | Zuanic & Associates | Initiate | Neutral |
| 2023-06-16 | CIBC | Maintains | Neutral |
| 2023-06-15 | Canaccord Genuity | Maintains | Hold |
| 2022-09-21 | Piper Sandler | Maintains | Neutral |
| 2021-09-28 | MKM Partners | Upgrade | Sell -> Neutral |
| 2021-05-17 | Stifel Nicolaus | Downgrade | |
| 2021-05-17 | CIBC World Markets | Downgrade | |
| 2021-05-14 | Cowen | Downgrade | |
| 2021-05-14 | ATB Capital | Downgrade | Sector Perform -> Underperform |
| 2021-05-14 | MKM Partners | Downgrade | |
| 2021-05-14 | CIBC World Markets | Downgrade | Underperform |
| 2021-05-11 | CIBC World Markets | Downgrade | Neutral -> Underperform |
| 2021-02-24 | Jefferies | Upgrade | |
| 2021-02-16 | CIBC World Markets | Upgrade | Underperform |
| 2021-02-12 | ATB Capital | Upgrade | Sector Perform |
| 2021-02-12 | Stifel Nicolaus | Upgrade | |
| 2021-02-12 | MKM Partners | Reiterate | Sell |
| 2021-02-12 | Canaccord Genuity | Upgrade | |
| 2021-02-08 | CIBC World Markets | Upgrade |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 221.339M -9.75% | 269.637M 21.82% | 343.293M 27.32% | 364.96M 6.31% | 340.8M -6.62% | 411.04M 20.61% | 353.73M -13.94% | 380.31M 7.51% | 409.5M 7.68% | 441.31M 7.77% | |
| EBITDA YoY % growth | -251.771M 12.63% | -141.588M 43.76% | -144.431M -2.01% | 56.644M 139.22% | 62.283M 9.96% | 64.17M 3.03% | 59.19M -7.76% | 73.384M 23.98% | 90.295M 23.04% | 110.83M 22.74% | |
| EBIT YoY % growth | -345.431M 10.56% | -174.363M 49.52% | -166.978M 4.24% | -25.105M 84.96% | 8.616M 134.32% | 55.045M 538.87% | 95.779M 74.00% | 108.86M 13.66% | 122.53M 12.56% | N/A | |
| Operating Margin | -156.06% | -64.67% | -48.64% | -6.88% | 2.53% | 13.39% | 27.08% | 28.62% | 29.92% | N/A | |
| EPS YoY % growth | N/A 87.80% | -0.82 -29.90% | 0.05 106.11% | -1.20 -2,493.70% | 0.08 106.75% | 0.28 241.66% | 1.51 447.62% | 1.75 15.64% | 2.00 14.29% | N/A |
All data in CAD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 80.49% | 0.03 112.47% | 0.06 127.81% | 0.09 214.21% | 0.00 100.00% |
| Revenue Q2Q % growth | 79.487M -12.21% | 81.972M -16.37% | 83.709M -7.37% | 88.718M -5.81% | 86.436M 8.74% |
| EBITDA Q2Q % growth | 12.443M 147.01% | 13.352M 131.54% | 15.493M 135.82% | 17.15M 201.00% | 17.19M 38.15% |
| EBIT Q2Q % growth | -6.715M 86.30% | 160.257K 100.33% | 1.825M 103.28% | 3.118M 108.71% | -1.719M 74.39% |
All data in CAD
10 analysts have analysed ACB and the average price target is 5.62 USD. This implies a price increase of 64.66% is expected in the next year compared to the current price of 3.415.
AURORA CANNABIS INC (ACB) will report earnings on 2026-06-16, after the market close.
The consensus EPS estimate for the next earnings of AURORA CANNABIS INC (ACB) is -0.09 USD and the consensus revenue estimate is 79.49M USD.
The consensus rating for AURORA CANNABIS INC (ACB) is 74 / 100 . This indicates that analysts generally have a positive outlook on the stock.